COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Covid19

Interventions

DRUG

Placebo

Placebo looks exactly like the study drug, but it contains no active ingredient.

DRUG

Fisetin

\~20 mg/kg/day oral, NG or D tube course for 2 consecutive days

Trial Locations (1)

Mayo Clinic in Rochester, Rochester